国产新药格列美脲片剂对健康受试者血糖的影响

Effect of Glimepiride on blood glucose concentrations in healthy volunteers

  • 摘要: 目的: 观察国产格列美脲片剂对健康受试者血糖浓度的影响。方法: 40名中国健康受试者经筛选体检后进入试验,随机分成8组,分别单次口服不同剂量格列美脲片,动态监测给药前1d、给药日和给药后1d血糖浓度,数据处理用SAS统计软件的单因素实验设计方差分析。结果: 格列美脲片剂2mg至10mg各组对中国健康受试者的血糖浓度均有不同的降低作用,给药日2mg至10mg剂量组在早晚后2h血糖浓度较给药前1d明显降低(P<0.05);给药日10mg剂量组午餐后2h、晚餐后2h、睡前9点血糖浓度显著低于其它剂量组同一时间血糖浓度(P<0.05)。结论: 口服国产格列美脲片2mg至10mg均能引起健康人体血糖浓度的下降,效应强度可能与药物剂量有关。

     

    Abstract: Objective: To study the effect of Glimepiride on the blood glucose concentrations in healthy volunteers. Methods: Forty healthy volunteers were divided into eight groups to receive a single dose of 1, 2, 4, 6, 8, 10 mg Glimepiride or placebo and blood glucose concentrations were determined on the pre administration day, the administration day and the post administration day. Moreover, a full physical examination and a series of laboratory examinations were taken before the trial conducted and the results were assessed by SAS software. Results: Blood glucose concentrations of healthy volunteers after administration of 2, 4, 6, 8 or 10 mg Glimepiride decreased significantly during 2 h after breakfast on the administration day compared with the pre administration day (P<0 05). The blood glucose concentrations at 2 h after lunch, supper and 9∶00 PM on the administration day in 10 mg Glimepiride group were significantly lower than those of other groups (P<0 05). Conclusion: A single dose of 2~10 mg Glimepiride in healthy volunteers decreased the blood glucose concentrations (P<0 05), which indicated a dose-response relationship.

     

/

返回文章
返回